Our previous findings indicate that there may be several targets for the inhibitory effects of α3(IV)NC1 on tumor-angiogenesis, including or in addition to COX-2, VEGF and bFGF (Boosani et al. 2007). The gene discussed is PTGS2; the disease is neoplasm.